IMBiologics
About:
IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.
Website: http://imbiologics.com
Top Investors: KB Investment, Atinum Partners, IMM Investment, Partners Investment, Timewise Investment
Description:
Total Funding Amount:
17B KRW
Headquarters Location:
Seongnam, Kyonggi-do, South Korea
Founded Date:
2020-01-01
Contact Email:
imbiologics(AT)imbiologics.com
Founders:
Number of Employees:
Last Funding Date:
2021-09-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai